Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

Recruiting N/A Interventional Study
BPH With Symptomatic Lower Urinary Tract Symptoms BPH With Urinary Obstruction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Smita De · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enucleation and is recommended by the American Urological Association (AUA), along with thulium laser en…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Understand and voluntarily sign an informed consent form. * Patients must be males with a prostate, at least 18 years of age * No prior prostate surgery Exclusion Criteria: * Unable/refuse to provide informed consent * Prior prostate surgery * Bladder stones that requiring l…
Contacts

Iva Markovic

216-636-9694

markovi@ccf.org

CONTACT

Smita De, MD, PHD

216-445-4818

des@ccf.org

CONTACT